Evolving Approaches for Pharmacological Therapy of Obesity
- PMID: 39348522
- PMCID: PMC11770897
- DOI: 10.1146/annurev-pharmtox-031124-101146
Evolving Approaches for Pharmacological Therapy of Obesity
Abstract
Obesity is a global health concern. Progress in understanding the physiology of obesity and weight reduction has provided new drug targets. Development and testing of new antiobesity medications (AOMs) has the potential to quickly expand options for treatment. In this review, we briefly summarize the physiology of obesity and weight reduction, as well as medications currently approved for weight management. We highlight the increasing use of incretin and nutrient-stimulated hormone-based therapies. We conclude with an overview of AOMs progressing through the pipeline and discuss their implications for the rapidly evolving field of obesity management.
Keywords: GLP-1RA; antiobesity medications; drugs; medications; obesity; weight.
Similar articles
-
Incretin-based therapies for obesity treatment.Metabolism. 2015 Sep;64(9):967-81. doi: 10.1016/j.metabol.2015.05.012. Epub 2015 May 23. Metabolism. 2015. PMID: 26072135 Review.
-
Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management.Pharmacotherapy. 2024 Sep;44(9):738-752. doi: 10.1002/phar.4607. Epub 2024 Sep 3. Pharmacotherapy. 2024. PMID: 39225417 Review.
-
Glucagon-like peptide-1 receptor agonists: the key to healthy weight loss maintenance?Cardiovasc Res. 2021 Aug 29;117(10):e120-e122. doi: 10.1093/cvr/cvab249. Cardiovasc Res. 2021. PMID: 34448813 No abstract available.
-
The incretin pathway as a new therapeutic target for obesity.Maturitas. 2010 Nov;67(3):197-202. doi: 10.1016/j.maturitas.2010.06.018. Epub 2010 Jul 23. Maturitas. 2010. PMID: 20655673 Review.
-
Extended-release naltrexone/bupropion is safe and effective among subjects with type 2 diabetes already taking incretin agents: a post-hoc analysis of the LIGHT trial.Int J Obes (Lond). 2021 Aug;45(8):1687-1695. doi: 10.1038/s41366-021-00831-4. Epub 2021 Jun 3. Int J Obes (Lond). 2021. PMID: 34083744 Free PMC article.
Cited by
-
Psychological Traits of Bariatric Surgery Candidates and Predictors of Outcomes.J Pers Med. 2025 May 26;15(6):215. doi: 10.3390/jpm15060215. J Pers Med. 2025. PMID: 40559078 Free PMC article.
-
Probiotic Potentials and Protective Effects of Ligilactobacillus animalis LA-1 Against High-Fat Diet-Induced Obesity in Mice.Nutrients. 2025 Jul 17;17(14):2346. doi: 10.3390/nu17142346. Nutrients. 2025. PMID: 40732971 Free PMC article.
References
-
- World Health Organization. 2000. Obesity: preventing and managing the global epidemic: report of a WHO consultation. - PubMed
-
- World Obesity Federation. 2023. World Obesity Atlas. https://data.worldobesity.org/publications/?cat=19
-
- Yuen M, Lui D, Kaplan L. 2016. A systematic review and evaluation of current evidence reveals 195 obesity-associated disorders (OBAD). Obesity Week
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical